AAAAAA

   
Results: 1-25 | 26-50 | 51-70
Results: 26-50/70
LYMPH-NODE ENLARGEMENT
Authors: FISCHER K DOHNER H HUNSTEIN W
Citation: K. Fischer et al., LYMPH-NODE ENLARGEMENT, Hautarzt, 46(2), 1995, pp. 131-139
TREATMENT OF SYSTEMIC MASTOCYTOSIS WITH INTERFERON-GAMMA - FAILURE AFTER APPEARANCE OF ANTI-IFN-GAMMA ANTIBODIES
Authors: FIEHN C PRUMMER O GALLATI H HEILIG B HUNSTEIN W
Citation: C. Fiehn et al., TREATMENT OF SYSTEMIC MASTOCYTOSIS WITH INTERFERON-GAMMA - FAILURE AFTER APPEARANCE OF ANTI-IFN-GAMMA ANTIBODIES, European journal of clinical investigation, 25(8), 1995, pp. 615-618
PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PRETREATED PATIENTS WITH MULTIPLE-MYELOMA - A SIGNIFICANTLY LOWER B-CELL CONTENT IN LEUKAPHERESIS PRODUCTS FOLLOWING 7 G M(2) COMPARED TO 7 G/M(2) CYCLOPHOSPHAMIDE/
Authors: GOLDSCHMIDT H HEGENBART U WALLMEIER M HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., PERIPHERAL-BLOOD PROGENITOR-CELL MOBILIZATION IN PRETREATED PATIENTS WITH MULTIPLE-MYELOMA - A SIGNIFICANTLY LOWER B-CELL CONTENT IN LEUKAPHERESIS PRODUCTS FOLLOWING 7 G M(2) COMPARED TO 7 G/M(2) CYCLOPHOSPHAMIDE/, Blood, 86(10), 1995, pp. 1596-1596
PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS DURING STEADY-STATE HEMATOPOIESIS ALLOW TO ESTIMATE THE YIELD OF MOBILIZED PBPC AFTER FILGRASTIM (R-METHUG-CSF)-SUPPORTED CYTOTOXIC CHEMOTHERAPY
Authors: FRUEHAUF S HAAS R CONRADT C MUREA S WITT B MOHLE R HUNSTEIN W
Citation: S. Fruehauf et al., PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) COUNTS DURING STEADY-STATE HEMATOPOIESIS ALLOW TO ESTIMATE THE YIELD OF MOBILIZED PBPC AFTER FILGRASTIM (R-METHUG-CSF)-SUPPORTED CYTOTOXIC CHEMOTHERAPY, Blood, 85(9), 1995, pp. 2619-2626
BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING GRANULOCYTE-COLONY-STIMULATING FACTOR-ENHANCED RECOVERY ARE ENRICHED WITH EARLY THY-1(+) HEMATOPOIETIC PROGENITOR CELLS
Authors: HAAS R MOHLE R PFORSICH M FRUEHAUF S WITT B GOLDSCHMIDT H HUNSTEIN W
Citation: R. Haas et al., BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING GRANULOCYTE-COLONY-STIMULATING FACTOR-ENHANCED RECOVERY ARE ENRICHED WITH EARLY THY-1(+) HEMATOPOIETIC PROGENITOR CELLS, Blood, 85(7), 1995, pp. 1936-1943
P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
Authors: DOHNER H FISCHER K BENTZ M HANSEN K BENNER A CABOT G DIEHL D SCHLENK R COY J STILGENBAUER S VOLKMANN M GALLE PR POUSTKA A HUNSTEIN W LICHTER P
Citation: H. Dohner et al., P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO THERAPY WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS, Blood, 85(6), 1995, pp. 1580-1589
SUSTAINED LONG-TERM HEMATOPOIESIS AFTER MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT
Authors: HAAS R WITT B MOHLE R GOLDSCHMIDT H HOHAUS S FRUEHAUF S WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SUSTAINED LONG-TERM HEMATOPOIESIS AFTER MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT, Blood, 85(12), 1995, pp. 3754-3761
HAIRY-CELL LEUKEMIA
Authors: DOHNER H HUNSTEIN W
Citation: H. Dohner et W. Hunstein, HAIRY-CELL LEUKEMIA, Deutsche Medizinische Wochenschrift, 119(17), 1994, pp. 642-642
DETECTION OF RESIDUAL TUMOR-CELLS IN PATIENTS WITH MALIGNANT-MELANOMARESPONDING TO IMMUNOTHERAPY
Authors: BROSSART P KEILHOLZ U SCHEIBENBOGEN C MOHLER T WILLHAUCK M HUNSTEIN W
Citation: P. Brossart et al., DETECTION OF RESIDUAL TUMOR-CELLS IN PATIENTS WITH MALIGNANT-MELANOMARESPONDING TO IMMUNOTHERAPY, Journal of immunotherapy with emphasis on tumor immunology, 15(1), 1994, pp. 38-41
CD34 SELECTION FOR PURGING IN MULTIPLE-MYELOMA AND ANALYSIS OF CD34(-CELL PRECURSORS() B)
Authors: FRUEHAUF S HAAS R ZELLER WJ HUNSTEIN W
Citation: S. Fruehauf et al., CD34 SELECTION FOR PURGING IN MULTIPLE-MYELOMA AND ANALYSIS OF CD34(-CELL PRECURSORS() B), Stem cells, 12(1), 1994, pp. 95-102
HLA CLASS-I ALLELES AND RESPONSIVENESS OF MELANOMA TO IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA) AND INTERLEUKIN-2 (IL-2)
Authors: SCHEIBENBOGEN C KEILHOLZ U MYTILINEOS J SUCIU S MANASTERSKI M HUNSTEIN W
Citation: C. Scheibenbogen et al., HLA CLASS-I ALLELES AND RESPONSIVENESS OF MELANOMA TO IMMUNOTHERAPY WITH INTERFERON-ALPHA (IFN-ALPHA) AND INTERLEUKIN-2 (IL-2), Melanoma research, 4(3), 1994, pp. 191-194
VITILIGO-LIKE LESIONS FOLLOWING IMMUNOTHERAPY WITH IFN-ALPHA AND IL-2IN MELANOMA PATIENTS
Authors: SCHEIBENBOGEN C HUNSTEIN W KEILHOLZ U
Citation: C. Scheibenbogen et al., VITILIGO-LIKE LESIONS FOLLOWING IMMUNOTHERAPY WITH IFN-ALPHA AND IL-2IN MELANOMA PATIENTS, European journal of cancer, 30A(8), 1994, pp. 1209-1211
IMMUNOTHERAPY OF METASTATIC MELANOMA WITH INTERFERON-ALPHA AMD INTERLEUKIN-2 - PATTERN OF PROGRESSION IN RESPONDERS AND PATIENTS WITH STABLE DISEASE WITH OR WITHOUT RESECTION OF RESIDUAL LESIONS
Authors: KEILHOLZ U SCHEIBENBOGEN C STOELBEN E SAEGER HD HUNSTEIN W
Citation: U. Keilholz et al., IMMUNOTHERAPY OF METASTATIC MELANOMA WITH INTERFERON-ALPHA AMD INTERLEUKIN-2 - PATTERN OF PROGRESSION IN RESPONDERS AND PATIENTS WITH STABLE DISEASE WITH OR WITHOUT RESECTION OF RESIDUAL LESIONS, European journal of cancer, 30A(7), 1994, pp. 955-958
REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES
Authors: KEILHOLZ U SCHEIBENBOGEN C BRADO M GEORGI P MACLACHLAN D BRADO B HUNSTEIN W
Citation: U. Keilholz et al., REGIONAL ADOPTIVE IMMUNOTHERAPY WITH INTERLEUKIN-2 AND LYMPHOKINE-ACTIVATED KILLER (LAK) CELLS FOR LIVER METASTASES, European journal of cancer, 30A(1), 1994, pp. 103-105
SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: HAAS R MOOS M KARCHER A MOHLE R WITT B GOLDSCHMIDT H FRUHAUF S FLENTJE M WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SEQUENTIAL HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN LOW-GRADE NON-HODGKINS-LYMPHOMA, Journal of clinical oncology, 12(8), 1994, pp. 1685-1692
MULTIDRUG-RESISTANCE PHENOTYPE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA AS DETECTED BY IMMUNOFLUORESCENCE (FACS) AND NORTHERN BLOT ANALYSIS
Authors: WULF G KLUDING H HO AD DOERNER M DOEHNER H MANEGOLD C HUNSTEIN W
Citation: G. Wulf et al., MULTIDRUG-RESISTANCE PHENOTYPE IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA AS DETECTED BY IMMUNOFLUORESCENCE (FACS) AND NORTHERN BLOT ANALYSIS, Leukemia research, 18(7), 1994, pp. 475-484
HIGH-DOSE THERAPY AND AUTOGRAFTING WITH PERIPHERAL-BLOOD STEM-CELLS IN MALIGNANT-LYMPHOMA - GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR STEM-CELL MOBILIZATION
Authors: HAAS R HOHAUS S GOLDSCHMIDT H MOHLE R WITT B WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., HIGH-DOSE THERAPY AND AUTOGRAFTING WITH PERIPHERAL-BLOOD STEM-CELLS IN MALIGNANT-LYMPHOMA - GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR STEM-CELL MOBILIZATION, Seminars in oncology, 21(6), 1994, pp. 19-24
ENLARGEMENT OF THE LYMPH-NODES
Authors: FISCHER K DOHNER H HUNSTEIN W
Citation: K. Fischer et al., ENLARGEMENT OF THE LYMPH-NODES, Der Internist, 35(3), 1994, pp. 301-309
MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AND DETECTION OF MINIMAL DISEASE IN PATIENTS WITH BREAST-CANCER
Authors: KRAMER A HAAS R MUREA S KIRSCH M PANTEL K RIETHMULLER G BASTERT W HUNSTEIN W
Citation: A. Kramer et al., MOBILIZATION OF PERIPHERAL-BLOOD PROGENITOR CELLS AND DETECTION OF MINIMAL DISEASE IN PATIENTS WITH BREAST-CANCER, Blood, 84(10), 1994, pp. 10000108-10000108
SEQUENTIAL POSITRON-EMISSION TOMOGRAPHY IN TREATED PATIENTS WITH MALIGNANT-LYMPHOMA
Authors: GOLDSCHMIDT H HEGENBART U DIMITRAKOPOULOUSTRAUSS A HAAS R STRAUSS LG HUNSTEIN W
Citation: H. Goldschmidt et al., SEQUENTIAL POSITRON-EMISSION TOMOGRAPHY IN TREATED PATIENTS WITH MALIGNANT-LYMPHOMA, Blood, 84(10), 1994, pp. 10000158-10000158
ANTIGENIC PROFILE AND PCR ANALYSIS OF PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTS IN MULTIPLE-MYELOMA
Authors: GOLDSCHMIDT H MOOS M CREMER F ATZBERGER A WITT B HAAS R HUNSTEIN W
Citation: H. Goldschmidt et al., ANTIGENIC PROFILE AND PCR ANALYSIS OF PERIPHERAL-BLOOD PROGENITOR-CELL AUTOGRAFTS IN MULTIPLE-MYELOMA, Blood, 84(10), 1994, pp. 10000385-10000385
P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO TREATMENT WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS
Authors: DOHNER H FISCHER K STILGENBAUER S BENTZ M HANSEN K WEISS G BENNER A SCHLENK R COY J VOLKMANN M GALLE PR HUNSTEIN W LICHTER P
Citation: H. Dohner et al., P53 GENE DELETION PREDICTS FOR POOR SURVIVAL AND NONRESPONSE TO TREATMENT WITH PURINE ANALOGS IN CHRONIC B-CELL LEUKEMIAS, Blood, 84(10), 1994, pp. 10000439-10000439
BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING G-CSF-ENHANCED RECOVERY AREENRICHED WITH EARLY THY-1+HEMATOPOIETIC PROGENITOR CELLS
Authors: HAAS R MOEHLE R PFOERSICH M FRUEHAUF S WITT B GOLDSCHMIDT H HUNSTEIN W
Citation: R. Haas et al., BLOOD-DERIVED AUTOGRAFTS COLLECTED DURING G-CSF-ENHANCED RECOVERY AREENRICHED WITH EARLY THY-1+HEMATOPOIETIC PROGENITOR CELLS, Blood, 84(10), 1994, pp. 10000499-10000499
DIFFERENTIAL COEXPRESSION OF INTEGRINS AND SELECTINS ON BLOOD-DERIVEDAND BONE-MARROW CD34+ CELLS
Authors: MOHLE R HAAS R HUNSTEIN W
Citation: R. Mohle et al., DIFFERENTIAL COEXPRESSION OF INTEGRINS AND SELECTINS ON BLOOD-DERIVEDAND BONE-MARROW CD34+ CELLS, Blood, 84(10), 1994, pp. 10000573-10000573
SUSTAINED LONG-TERM HEMATOPOIESIS FOLLOWING MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT
Authors: HAAS R WITT B MOHLE R GOLDSCHMIDT H HOHAUS S FRUHAUF S WANNENMACHER M HUNSTEIN W
Citation: R. Haas et al., SUSTAINED LONG-TERM HEMATOPOIESIS FOLLOWING MYELOABLATIVE THERAPY WITH PERIPHERAL-BLOOD PROGENITOR-CELL (PBPC) SUPPORT, Blood, 84(10), 1994, pp. 10000710-10000710
Risultati: 1-25 | 26-50 | 51-70